These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
332 related articles for article (PubMed ID: 12119909)
1. [When statins alone are not enough. Putting a vice grip on cholesterol]. MMW Fortschr Med; 2002 Jun; 144(23):52-3. PubMed ID: 12119909 [No Abstract] [Full Text] [Related]
2. When a statin fails. Med Lett Drugs Ther; 2009 Jul; 51(1317):58-60. PubMed ID: 19636290 [No Abstract] [Full Text] [Related]
3. [Recommended LDL value far lower. How does one achieve this goal?]. Einecke D MMW Fortschr Med; 2004 Mar; 146(13):6. PubMed ID: 15219116 [No Abstract] [Full Text] [Related]
4. [Statins remain the standard. New methods for lipid lowering therapy]. Aumiller J MMW Fortschr Med; 2001 Oct; 143(42):16-7. PubMed ID: 11697281 [No Abstract] [Full Text] [Related]
5. [Hyperlipidemia: decreasing lipid values and effects of statins]. Mathes P Z Kardiol; 2002; 91 Suppl 2():25-9. PubMed ID: 12436762 [No Abstract] [Full Text] [Related]
6. [Decreasing LDL level moderately or drastically. Is differential therapy with statins available? (interview by Dirk Einecke)]. März W MMW Fortschr Med; 2004 Jul; 146(27-28):53. PubMed ID: 15526673 [No Abstract] [Full Text] [Related]
16. Consistency in efficacy and safety of ezetimibe coadministered with statins for treatment of hypercholesterolemia in women and men. Bennett S; Sager P; Lipka L; Melani L; Suresh R; Veltri E; J Womens Health (Larchmt); 2004 Dec; 13(10):1101-7. PubMed ID: 15650343 [TBL] [Abstract][Full Text] [Related]
17. New developments in pharmacotherapy. Thompson GR Cardiovasc J S Afr; 2004; 15(2):56-8. PubMed ID: 15148538 [No Abstract] [Full Text] [Related]
18. Is it appropriate to make statins available over the counter? The argument against the appropriateness of over-the-counter statins. Barter PJ; Rye KA Circulation; 2006 Sep; 114(12):1315-20; discussion 1320. PubMed ID: 16982953 [No Abstract] [Full Text] [Related]
19. Effect of ezetimibe on low-density lipoprotein subtype distribution: results of a placebo-controlled, double-blind trial in patients treated by regular low-density lipoprotein apheresis and statins. Geiss HC; Otto C; Parhofer KG Metabolism; 2006 May; 55(5):599-604. PubMed ID: 16631435 [TBL] [Abstract][Full Text] [Related]
20. Overlap analysis of the West of Scotland coronary prevention study (WOSCOPS). Lim PO; Yee KM Circulation; 1999 Aug; 100(6):686. PubMed ID: 10441109 [No Abstract] [Full Text] [Related] [Next] [New Search]